Avidity Partners Management LP Purchases 5,900 Shares of Neurocrine Biosciences, Inc. (NASDAQ:NBIX)
Avidity Partners Management LP lifted its stake in Neurocrine Biosciences, Inc. (NASDAQ:NBIX – Free Report) by 0.9% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 658,000 shares of the company’s stock after purchasing an additional 5,900 shares during the quarter. Neurocrine Biosciences accounts for […]
More Stories
Parimatch: Your Trusted Platform for Online Betting and Gaming in Canada
Parimatch has quickly gained recognition as one of the most reliable and user-friendly platforms for sports betting and online gaming...
Analysts Set Brookfield Asset Management Ltd. (NYSE:BAM) PT at $53.88
Brookfield Asset Management Ltd. (NYSE:BAM – Get Free Report) (TSE:BAM.A) has earned an average rating of “Hold” from the thirteen...
Semtech Co. (NASDAQ:SMTC) Given Consensus Rating of “Moderate Buy” by Analysts
Shares of Semtech Co. (NASDAQ:SMTC – Get Free Report) have been given a consensus rating of “Moderate Buy” by the...
The Cigna Group (NYSE:CI) Given Average Rating of “Buy” by Brokerages
The Cigna Group (NYSE:CI – Get Free Report) has received an average rating of “Buy” from the fifteen ratings firms...
Red Rock Resorts Amends Credit Agreement, Reducing Interest Rates
Red Rock Resorts, Inc. (NASDAQ:RRR) reported today the entry into an agreement that significantly impacts its financial structure. On December...
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives $42.33 Average PT from Analysts
Edgewise Therapeutics, Inc. (NASDAQ:EWTX – Get Free Report) has received a consensus rating of “Buy” from the six ratings firms...